• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
LTP

LTR PHARMA LIMITED

19.4% ! 55.5¢
Market Cap $61.57M  !

LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The... LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is developing and commercializing therapies that address significant unmet medical needs. The Company is focused on improving men’s health through clinical development and commercialization of nasal spray treatments for erectile dysfunction. Its lead products, SPONTAN and ROXUS, are fast-acting intranasal sprays for the treatment of erectile dysfunction, enabling onset of action in 10 minutes or less. The Company is also advancing OROFLOW, a novel intranasal spray under development for the treatment of Oesophageal Motility Disorders (OMD) - a debilitating group of conditions affecting swallowing function. The Company's subsidiary is LTR Pharma Inc.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
LTP 11:48 20 4.8K
11:48 Last post  ibuyhigh Comments Created with Sketch.  20  Views Created with Sketch.  4.8K 
LTP 29/08/25 0 114
29/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  114 
LTP 29/08/25 0 171
29/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  171 
LTP
Chart
2 3
28/08/25 132 34K
28/08/25 Last post  Domske Comments Created with Sketch.  132  Views Created with Sketch.  34K 
LTP 26/08/25 16 4.9K
26/08/25 Last post  originenergysux Comments Created with Sketch.  16  Views Created with Sketch.  4.9K 
LTP 25/08/25 7 2.1K
25/08/25 Last post  stevemol Comments Created with Sketch.  7  Views Created with Sketch.  2.1K 
LTP 22/08/25 10 2.8K
22/08/25 Last post  Gordy56 Comments Created with Sketch.  10  Views Created with Sketch.  2.8K 
LTP 20/08/25 321 128K
20/08/25 Last post  chuk Comments Created with Sketch.  321  Views Created with Sketch.  128K 

See All Discussions arrow Created with Sketch.

Timeline

FY25 Results Announcement
29 Aug 08:49
 
Appendix 4G and Corporate Governance Statement
29 Aug 08:49
 
Appendix 4E and Annual Report to Shareholders
29 Aug 08:48
 
SPONTAN Case Series - Strong Post-Prostatectomy Results
25 Aug 09:04
 
18-Month Shelf Life Strengthens SPONTAN Commercialisation
22 Aug 09:23
 
SPONTAN 5x Faster Onset Validated in EU Journal
20 Aug 09:15
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
55.5¢
Change
0.090(19.4%)
Mkt cap ! $61.57M
Open High Low Value Volume
47.5¢ 57.0¢ 47.5¢ $1.474M 2.752M

Buyers (Bids)

No. Vol. Price($)
1 10000 55.0¢
 

Sellers (Offers)

Price($) Vol. No.
56.0¢ 4511 2
View Market Depth
Last trade - 14.54pm 12/09/2025 (20 minute delay) ?
Last
55.5¢
  Change
0.090 ( 19.4 %)
Open High Low Volume
47.5¢ 57.0¢ 47.5¢ 223281
Last updated 15.15pm 12/09/2025 ?
LTP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.